7774.T JPX
Japan Tissue Engineering Co., Ltd.
1W: -1.8%
1M: -3.6%
3M: +33.5%
YTD: +40.2%
1Y: +56.0%
3Y: +46.4%
5Y: +7.3%
¥831.00 ($5.26)
-2.00 (-0.24%)
Weekly Expected Move ±8.3%
¥695
¥764
¥833
¥902
¥971
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$148M
-154.1% ▼
Capital Expenditures
$76M
+72.1% ▲
5Y CAGR: -3.6%
Free Cash Flow
-$224M
-24032.2% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$3K
+0.0% ▲
Net Change in Cash
-$381M
-1298.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$463M | -$494M | -$725M | $143M | -$255M |
| Depreciation & Amort. | $128M | $125M | $131M | $134M | $158M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$83M | $220M | -$115M | -$15M | -$44M |
| Other Non-Cash Items | $18M | -$76M | $86M | $12M | -$7M |
| Operating Cash Flow | -$400M | -$225M | -$623M | $274M | -$148M |
| — Investing Activities — | |||||
| Capital Expenditures | -$74M | -$117M | -$176M | -$196M | -$94M |
| Acquisitions (Net) | -$12M | -$15M | -$27M | $0 | $0 |
| Investment Purchases | -$3.4B | -$3.4B | -$2.1B | -$2.2B | -$2.4B |
| Investment Sales | $3.6B | $3.4B | $3.4B | $2.1B | $2.2B |
| Other Investing | $12M | $15M | $28M | $54M | $11M |
| Investing Cash Flow | $126M | -$116M | $1.1B | -$242M | -$233M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1M | -$803K | -$803K | -$133K | $0 |
| Stock Repurchased | $0 | -$20K | $0 | $0 | -$3K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | -$1K | $0 |
| Financing Cash Flow | -$1M | -$823K | -$803K | -$134K | -$3K |
| Net Change in Cash | -$275M | -$343M | $501M | $32M | -$381M |
| Cash End of Period | $1.9B | $1.5B | $2.0B | $2.1B | $1.7B |
| Free Cash Flow | -$474M | -$342M | -$799M | $938K | -$224M |